Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland
- 1 September 2020
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 147 (10) , 2793-2800
Abstract
In designing national strategies for genetic testing, it is important to define the full spectrum of pathogenic mutations in prostate cancer (PCa) susceptibility genes. To investigate the frequency of mutations in PCa susceptibility genes in Polish familial PCa cases and to estimate gene‐related PCa risks and probability of aggressive disease, we analyzed the coding regions of 14 genes by exome sequencing in 390 men with familial prostate cancer and 308 cancer‐free controls. We compared the mutation frequencies between PCa cases and controls. We also compared clinical characteristics of prostate cancers between mutation carriers and noncarriers. Of the 390 PCa cases, 76 men (19.5%) carried a mutation in BRCA1, BRCA2, NBN, ATM, CHEK2, HOXB13, MSH2 or MSH6 genes. No mutations were found in BRIP1, PTEN, TP53, MLH1, PMS2 and SPOP. Significant associations with familial PCa risk were observed for CHEK2, NBN, ATM, and HOXB13. High‐grade (Gleason 8‐10) tumors were seen in 56% of BRCA2, NBN or ATM carriers, compared to 21% of patients who tested negative for mutations in these genes (OR = 4.7, 95% CI 2.0‐10.7, P = .0003). In summary, approximately 20% of familial prostate cancer cases in Poland can be attributed to mutations in eight susceptibility genes. Carriers of mutations in BRCA2, NBN and ATM develop aggressive disease and may benefit from intensified screening and/or chemotherapy.Keywords
Funding Information
- Narodowe Centrum Nauki (2015/19/B/NZ2/02439)
This publication has 32 references indexed in Scilit:
- Identification of a novel NBN truncating mutation in a family with hereditary prostate cancerFamilial Cancer, 2012
- Germline Mutations inHOXB13and Prostate-Cancer RiskNew England Journal of Medicine, 2012
- Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer FamiliesCancer Prevention Research, 2011
- Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosisBritish Journal of Cancer, 2010
- A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancerBritish Journal of Cancer, 2009
- Rapid progression of prostate cancer in men with a BRCA2 mutationBritish Journal of Cancer, 2008
- Role of the Nijmegen Breakage Syndrome 1 Gene in Familial and Sporadic Prostate CancerCancer Epidemiology, Biomarkers & Prevention, 2006
- Mutations in CHEK2 Associated with Prostate Cancer RiskThe American Journal of Human Genetics, 2003
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Family history and the risk of prostate cancerThe Prostate, 1990